2268 — WuXi XDC Cayman Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapFalling Star

Annual income statement for WuXi XDC Cayman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	311	990	2,124	4,052	5,944
Cost of Revenue
Gross Profit	113	261	560	1,240	2,139
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	244	792	1,763	2,829	4,191
Operating Profit	67.3	199	360	1,223	1,754
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	66.9	196	360	1,220	1,737
Provision for Income Taxes
Net Income After Taxes	54.9	156	284	1,070	1,480
Net Income Before Extraordinary Items
Net Income	54.9	156	284	1,070	1,480
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	54.9	156	284	1,070	1,480
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.047	0.132	0.303	0.831	1.14